HIV/AIDS Mental Health
Dehydroepiandrosterone appears to treat depression in HIV/AIDS
Published in Mental Health Weekly Digest, March 6th, 2006
According to a study from the United States, "Subsyndromal major depressive disorder is common among HIV-positive adults. This study was designed to assess the efficacy of dehydroepiandrosterone (DHEA) as a potential treatment.
"One hundred forty-five patients with subsyndromal depression or dysthymia were randomly assigned to receive either DHEA or placebo; 90% (69 of 77) of the DHEA patients and 94% (64 of 68) of the placebo patients completed the 8-week trial."
"The primary measure of efficacy was a Clinical Global Impression improvement rating of 1 or 2 (much or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Weekly Digest
More Articles from Mental Health Weekly Digest
- Borderline Personality Disorder
Few effective treatments exist for borderline personality disorder - Depression
Report finds depression drains more than $83 billion annually from the American economy - Disease Management
Team care for older adults with diabetes, depression improves health - Suicide Risk Factors
Newer antidepressant drugs do not increase suicide risk - Alcohol Use
AA-AGE cytotoxicity is important in alcoholic-induced neuronal degeneration - Alcohol Use
Ethanol consumption level is related to individual lifestyle status - More from this issue of Mental Health Weekly Digest
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
